Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review (Q24635097)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review	scientific article

Statements

instance of

scholarly article

0 references

systematic review

1 reference

based on heuristic

inferred from title

review article

1 reference

stated in

Europe PubMed Central

title

Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review (English)

0 references

main subject

chronic obstructive pulmonary disease

0 references

systematic review

1 reference

based on heuristic

inferred from title

author

Phillippa Poole

series ordinal

1

object named as

P J Poole

0 references

Peter Black

series ordinal

2

object named as

P N Black

0 references

language of work or name

English

0 references

publication date

26 May 2001

0 references

published in

The BMJ

0 references

volume

322

0 references

issue

7297

0 references

page(s)

1271-4

0 references

cites work

Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

Mucoactive drugs in the management of chronic obstructive pulmonary disease.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immuno

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

Attenuation of oxidant/antioxidant imbalance during treatment of exacerbations of chronic obstructive pulmonary disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

Assessing the quality of randomized controlled trials. Current issues and future directions

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

The statistical basis of meta-analysis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

Drugs active on mucus in the primary treatment of chronic bronchitis. Controlled study of the activity of letosteine

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

27 September 2017

N-acetylcysteine reduces the exacerbation rate in patients with moderate to severe COPD.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

30 May 2018

S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

30 May 2018

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

30 May 2018

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

28 November 2018

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

28 November 2018

Effect of long-term treatment with sobrerol on the exacerbations of chronic bronchitis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=31920

retrieved

28 November 2018

Cost-effectiveness analysis of oral N-acetylcysteine as a preventive treatment in chronic bronchitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term oral acetylcysteine in chronic bronchitis. a double-blind controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of oral acetylcysteine (Fabrol) in chronic bronchitis: a double-blind placebo controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral Fabrol (oral N-acetyl-cysteine) in chronic bronchitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in days of illness after long-term treatment with N-acetylcysteine controlled-release tablets in patients with chronic bronchitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapy over 2 years with ambroxol (Mucosolvan) retard capsules in patients with chronic bronchitis. Results of a double-blind study of 180 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in COPD morbidity and mortality in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodinated glycerol has no effect on pulmonary function, symptom score, or sputum properties in patients with stable chronic bronchitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N‐isobutyrylcysteine, a donor of systemic thiols, does not reduce the exacerbation rate in chronic bronchitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mucolytic treatment of chronic bronchitis during two winter periods

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11375228

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1136/BMJ.322.7297.1271

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

729471

OpenCitations bibliographic resource ID

729471

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

729471

PMC publication ID

31920

0 references

PubMed publication ID

11375228

0 references

ResearchGate publication ID

11963657

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24635097&oldid=2047439575"